Michael Goldberg - EHealth Lead Independent Director
| EHTH Stock | USD 4.61 0.27 6.22% |
Director
Mr. Michael D. Goldberg is an Independent Director of eHealth Inc. Mr. Goldberg has served as a director since June 1999. Mr. Goldberg has served as the executive chairman of DNAnexus, Inc., a cloudbased genomic data company, and as an advisor at other private life science companies since May 2011. From January 2005 to May 2011, Mr. Goldberg was a partner at Mohr Davidow Ventures, a VC firm. From October 2000 to December 2004, Mr. Goldberg served as a managing director of Jasper Capital, a management and financial consultancy business. In 1995, Mr. Goldberg founded OnCare, Inc., an oncology practice management company, and served as its chief executive officer until March 1999 and as its chairman until August 2001. Mr. Goldberg previously served as founder, president and chief executive officer of Axion, Inc., a cancerfocused healthcare service company, from 1987 to 1995. Mr. Goldberg holds a B.A. in philosophy from Brandeis University and an M.B.A from the Stanford Graduate School of Business. Mr. Goldberg serves as the chairman of the board of directors of CareDx, Inc since 2016.
| Age | 60 |
| Tenure | 8 years |
| Address | 13620 Ranch Road 620 North, Austin, TX, United States, 78717 |
| Phone | (737) 248 2340 |
| Web | https://www.ehealthinsurance.com |
Michael Goldberg Latest Insider Activity
Tracking and analyzing the buying and selling activities of Michael Goldberg against EHealth stock is an integral part of due diligence when investing in EHealth. Michael Goldberg insider activity provides valuable insight into whether EHealth is net buyers or sellers over its current business cycle. Note, EHealth insiders must abide by specific rules, including filing SEC forms every time they buy or sell EHealth'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Michael Goldberg over two weeks ago Acquisition by Michael Goldberg of 3686 shares of Caredx subject to Rule 16b-3 |
EHealth Management Efficiency
The company has return on total asset (ROA) of (0.0163) % which means that it has lost $0.0163 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.031) %, meaning that it created substantial loss on money invested by shareholders. EHealth's management efficiency ratios could be used to measure how well EHealth manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.04. The current Return On Capital Employed is estimated to decrease to -0.02. As of now, EHealth's Intangible Assets are increasing as compared to previous years. The EHealth's current Net Tangible Assets is estimated to increase to about 1.1 B, while Other Assets are projected to decrease to under 147.4 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Oprah Winfrey | Willis Towers Watson | 62 | |
| Frank English | Arthur J Gallagher | 73 | |
| Thilo Semmelbauer | Willis Towers Watson | 52 | |
| Lawrence Gellerstedt | Brown Brown | 64 | |
| James Hunt | Brown Brown | 65 | |
| Philippe Amouyal | Willis Towers Watson | 58 | |
| Steven Altschuler | Willis Towers Watson | 63 | |
| Sherry Barrat | Arthur J Gallagher | 71 | |
| George Lucore | Erie Indemnity | 66 | |
| Teresa Clarke | Arthur J Gallagher | 58 | |
| Ralph Nicoletti | Arthur J Gallagher | 63 | |
| Alan Hoops | CorVel Corp | 69 | |
| Toni Jennings | Brown Brown | 71 | |
| Wendell Reilly | Brown Brown | 63 | |
| Jeffrey Michael | CorVel Corp | 60 | |
| Samuel Bell | Brown Brown | 80 | |
| Theodore Hoepner | Brown Brown | 79 | |
| Thomas Palmer | Erie Indemnity | 69 | |
| Hugh Brown | Brown Brown | 85 | |
| Richard Stover | Erie Indemnity | 74 | |
| Brian Hudson | Erie Indemnity | 62 | |
Management Performance
| Return On Equity | -0.031 | ||||
| Return On Asset | -0.0163 |
eHealth Leadership Team
Elected by the shareholders, the EHealth's board of directors comprises two types of representatives: EHealth inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EHealth. The board's role is to monitor EHealth's management team and ensure that shareholders' interests are well served. EHealth's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EHealth's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kate CFA, Senior Strategy | ||
| Michael Goldberg, Lead Independent Director | ||
| John Dolan, Chief Officer | ||
| Bill Billings, Chief Officer | ||
| Randy Livingston, Independent Director | ||
| David Francis, CFO | ||
| Robert Hurley, Sr. VP of Sales and Operations | ||
| Kate Sidorovich, IR Contact Officer | ||
| Ellen Tauscher, Independent Director | ||
| Scott Flanders, Independent Director | ||
| John Stelben, Senior CFO | ||
| Gary Lauer, Chairman, CEO and Member of Equity Incentive Committee | ||
| Tim Hannan, Chief Marketing Officer | ||
| John Oliver, Independent Director | ||
| Andrea Brimmer, Director | ||
| Jana Brown, Senior Officer | ||
| Tom Tsao, Chief Technology and Product Officer and Executive VP | ||
| William Shaughnessy, President, COO and Director | ||
| Ian Kalin, CTO | ||
| Francis Soistman, CEO Director | ||
| Gavin Galimi, General VP | ||
| Jack Oliver, Independent Director | ||
| Bob Rees, Chief Officer | ||
| Stuart Huizinga, CFO, Principal Accounting Officer and Sr. VP | ||
| Randall Livingston, Independent Director | ||
| Jay Jennings, Senior Vice President - Finance, Principal Accounting Officer | ||
| Michelle Barbeau, Chief Officer | ||
| Lara Sasken, Senior Communications | ||
| Dave Nicklaus, Senior Vice President - Sales and Operations | ||
| Roman Rariy, COO Officer | ||
| Timothy Hannan, Chief Marketing Officer | ||
| Gregg Ratkovic, Senior Officer | ||
| Derek Yung, CFO, Senior Vice President |
EHealth Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EHealth a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.031 | ||||
| Return On Asset | -0.0163 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | 0.24 % | ||||
| Current Valuation | 412.96 M | ||||
| Shares Outstanding | 28.94 M | ||||
| Shares Owned By Insiders | 5.77 % | ||||
| Shares Owned By Institutions | 76.54 % | ||||
| Number Of Shares Shorted | 1.11 M | ||||
| Price To Earning | 2.54 X |
Pair Trading with EHealth
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EHealth position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EHealth will appreciate offsetting losses from the drop in the long position's value.Moving together with EHealth Stock
| 0.68 | FANH | Fanhua Inc | PairCorr |
Moving against EHealth Stock
| 0.6 | DIST | Distoken Acquisition | PairCorr |
| 0.55 | C | Citigroup Financial Report 12th of July 2024 | PairCorr |
| 0.44 | BRP | Brp Group Financial Report 14th of May 2024 | PairCorr |
| 0.43 | ERIE | Erie Indemnity Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to EHealth could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EHealth when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EHealth - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling eHealth to buy it.
The correlation of EHealth is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EHealth moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if eHealth moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EHealth can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in eHealth. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for EHealth Stock analysis
When running EHealth's price analysis, check to measure EHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EHealth is operating at the current time. Most of EHealth's value examination focuses on studying past and present price action to predict the probability of EHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EHealth's price. Additionally, you may evaluate how the addition of EHealth to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is EHealth's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EHealth. If investors know EHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.108 | Earnings Share (2.37) | Revenue Per Share 16.165 | Quarterly Revenue Growth 0.262 | Return On Assets (0.02) |
The market value of eHealth is measured differently than its book value, which is the value of EHealth that is recorded on the company's balance sheet. Investors also form their own opinion of EHealth's value that differs from its market value or its book value, called intrinsic value, which is EHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EHealth's market value can be influenced by many factors that don't directly affect EHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if EHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.